Replimune investors face October 5 lead-plaintiff deadline after RP1 rejection
AI Summary- Robbins LLP filed a class action concerning Replimune securities purchased during the stated class period.
- Replimune shares fell 19.46% to $4.76 on April 10, 2026, before trading was halted.
- Investors seeking lead-plaintiff appointment must submit papers by October 5, 2026.